TriangleBiopsy Procedure (NCT07050186)
Biopsy Procedure trial for Metastatic NUT Carcinoma (NCT07050186). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with metastatic or unresectable NUT carcinoma when standard measures are unavailable or no longer control disease. NUT expression or gene translocation must confirm the diagnosis.
The idea: cemiplimab blocks PD-1, intended to release immune restraints. It is infused over thirty minutes every three weeks for up to 32 cycles. Researchers measure survival at six months, tumor responses, and safety. Prior PD-1/PD-L1 treatment is excluded. Study tumor biopsies are optional.
This phase 2 study plans 15 patients. Jochen Lorch leads at Northwestern in Chicago, one recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.